• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,315.04 77.05
( 0.10%)
Global Indices
Nasdaq
49,543.85 -540.61
(-1.08%)
Dow Jones
7,428.26 -93.98
(-1.25%)
Hang Seng
60,874.73 -534.56
(-0.87%)
Nikkei 225
10,172.40 -200.53
(-1.93%)
Forex
USD-INR
95.71 0.07
(0.07%)
EUR-INR
111.93 -0.13
(-0.12%)
GBP-INR
129.01 -0.31
(-0.24%)
JPY-INR
0.61 0.00
(-0.09%)

EQUITY - MARKET SCREENER

RPG Life Sciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532983
INE105J01010
366.0261581
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
RPGLIFE
33.82
3796.78
EPS(TTM)
Face Value()
Div & Yield %
67.87
8
1.05
 

genpharmasec limited
Lloyds Enterprises announces CCI approval for scheme of merger
May 14,2026
Lloyds Enterprises announced that  Competition Commission of India (CCI) has approved the proposed scheme of merger by absorption of Lloyds Infrastructure & Construction (transferor company 1), Metalfab Hightech (transferor company 2) and Techno Industries (transferor company 3) with Lloyds Engineering Works (transferee Company/ material subsidiary of Lloyds Enterprises).